79 related articles for article (PubMed ID: 1937065)
1. Catecholamine and acetylcholine in the rat cerebral cortex with special reference to pathogenetic mechanisms of Alzheimer's disease.
Shiosaka S; Yamano M; Tsuchiyama M; Kudo Y; Imaizumi K; Tohyama M
Gerontology; 1991; 37 Suppl 1():17-23. PubMed ID: 1937065
[TBL] [Abstract][Full Text] [Related]
2. Direct synaptic contacts of catecholamine fibers on neuropeptide Y-containing neurons of the rat cerebral cortex.
Tsuchiyama M; Kubota Y; Sugita M; Usuda S; Yamano M; Tohyama M
Brain Res; 1989 Aug; 494(1):168-71. PubMed ID: 2569916
[TBL] [Abstract][Full Text] [Related]
3. An attempt to cause the selective loss of the cholinergic neurons in the basal forebrain of the rat: a new animal model of Alzheimer's disease.
Kudo Y; Shiosaka S; Matsuda M; Tohyama M
Neurosci Lett; 1989 Jul; 102(2-3):125-30. PubMed ID: 2682384
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin protects cholinergic neurons against basal forebrain lesion.
Sugaya K; Takahashi M; Kubota K
Jpn J Pharmacol; 1992 May; 59(1):125-8. PubMed ID: 1507652
[TBL] [Abstract][Full Text] [Related]
5. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of cholinergic basal forebrain lesions on neuropeptide Y and somatostatin immunoreactivity in rat neocortex.
Gaykema RP; Compaan JC; Nyakas C; Horvath E; Luiten PG
Brain Res; 1989 Jun; 489(2):392-6. PubMed ID: 2568159
[TBL] [Abstract][Full Text] [Related]
7. Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease.
Jhamandas JH; Harris KH; MacTavish D; Jassar BS
J Neurophysiol; 2002 Feb; 87(2):696-704. PubMed ID: 11826038
[TBL] [Abstract][Full Text] [Related]
8. Morphological characterization of electrophysiologically and immunohistochemically identified basal forebrain cholinergic and neuropeptide Y-containing neurons.
Duque A; Tepper JM; Detari L; Ascoli GA; Zaborszky L
Brain Struct Funct; 2007 Jul; 212(1):55-73. PubMed ID: 17717698
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.
Orta-Salazar E; Cuellar-Lemus CA; Díaz-Cintra S; Feria-Velasco AI
Neurologia; 2014 Oct; 29(8):497-503. PubMed ID: 23433740
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model.
Nikolajsen GN; Jensen MS; West MJ
Neurobiol Aging; 2011 Nov; 32(11):1927-31. PubMed ID: 21752495
[TBL] [Abstract][Full Text] [Related]
11. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
12. [Study on Alzheimer's disease and the animal disease model--special reference to acetylcholinergic system].
Ueki A; Taira H; Miyoshi I
Seishin Shinkeigaku Zasshi; 1989; 91(10):736-50. PubMed ID: 2626496
[No Abstract] [Full Text] [Related]
13. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
[TBL] [Abstract][Full Text] [Related]
15. [Selective vulnerability of peptide-containing neurons in cerebral ischemia; immunohistochemical study].
Ueno M; Itakura T; Okuno T; Naka Y; Nakai K; Yokote H; Komai N
No Shinkei Geka; 1991 Nov; 19(11):1033-8. PubMed ID: 1684833
[TBL] [Abstract][Full Text] [Related]
16. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex.
Gabriel SM; Bierer LM; Harotunian V; Purohit DP; Perl DP; Davis KL
Neurosci Lett; 1993 May; 155(1):116-20. PubMed ID: 8103205
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
18. Combined damage to entorhinal cortex and cholinergic basal forebrain neurons, two early neurodegenerative features accompanying Alzheimer's disease: effects on locomotor activity and memory functions in rats.
Traissard N; Herbeaux K; Cosquer B; Jeltsch H; Ferry B; Galani R; Pernon A; Majchrzak M; Cassel JC
Neuropsychopharmacology; 2007 Apr; 32(4):851-71. PubMed ID: 16760925
[TBL] [Abstract][Full Text] [Related]
19. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat.
Barbelivien A; Vaussy C; Marchalant Y; Maubert E; Bertrand N; Beley A; Roussel S; Mackenzie ET; Dauphin F
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1255-66. PubMed ID: 15545921
[TBL] [Abstract][Full Text] [Related]
20. Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance.
Craft TK; Mahoney JH; Devries AC; Sarter M
Eur J Neurosci; 2005 Jun; 21(11):3117-32. PubMed ID: 15978021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
